Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Market Cap	304.97M
Revenue (ttm)	361.97M
Net Income (ttm)	21.53M
Shares Out	141.84M
EPS (ttm)	0.15
PE Ratio	14.17
Forward PE	n/a
Dividend	0.11 (5.12%)
Ex-Dividend Date	Jun 25, 2025

Volume	3,000
Average Volume	25,120
Open	2.150
Previous Close	2.150
Day's Range	2.150 - 2.150
52-Week Range	1.980 - 2.550
Beta	-0.00
RSI	56.46
Earnings Date	Nov 19, 2025

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also m...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,381
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2024, KLSE:YSPSAH's revenue was 368.66 million, an increase of 3.85% compared to the previous year's 355.00 million. Earnings were 26.69 million, a decrease of -28.48%.